EP3924340
INDASÓLÝLÍSOXASÓLAFLEIÐUR TIL AÐ MEÐHÖNDLA SJÚKDÓMA Á BORÐ VIÐ KRABBAMEIN
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.2.2020EP published:
29.1.2025EP application number:
20708434.4
EP translation filed:
19.2.2025Grant published:
15.3.2025EPO information:
European Patent Register
Max expiry date:
9.2.2040Expiry date:
9.2.2027Next due date:
28.2.2027
Title in English:
INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCERLanguage of the patent:
English
Timeline
Today
10.2.2020EP application
29.1.2025EP Publication
19.2.2025Translation submitted
15.3.2025Registration published
9.2.2027Expires
Owner
Name:
Merck Patent GmbHAddress:
Frankfurter Strasse 250, 64293 Darmstadt, DE
Inventor
Name:
DORSCH, DieterAddress:
64372 Ober-Ramstadt, DE
Name:
BLUM, AndreasAddress:
64625 Bensheim, DE
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
19156318Date:
11.2.2019Country:
EP
Classification
Categories:
C07D 231/56, C07D 413/04, C07D 413/14, C07D 417/14, C07D 471/04, C07D 471/10, C07D 487/04, C07D 491/048, C07D 491/08, C07D 491/107, A61P 35/00, C07C 49/86, C07C 309/30, A61K 31/416
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 28.4.2025
Expires: 9.2.2026
Payer: Árnason Faktor ehf.
Number: 7
Paid: 13.2.2026
Expires: 9.2.2027
Payer: Árnason Faktor ehf.